Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ceva-Phylaxia is a prominent global developer and manufacturer of veterinary biologicals, headquartered in Budapest, Hungary. As a major subsidiary of Ceva Santé Animale, the company specializes in the research, development, and large-scale production of vaccines for the poultry and swine industries. It is recognized for pioneering advanced vaccine technologies, including immune-complex vaccines and vector-based solutions that allow for in-ovo or day-old administration. The Budapest site serves as one of the largest and most sophisticated veterinary vaccine production facilities in the world, exporting products to over 100 countries. Ceva-Phylaxia plays a critical role in global food security by providing tools to control infectious diseases in livestock.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceva-Phylaxia.